“PERSONALIZED THERAPY IN CARDIOLOGY: THE ROLE OF PHARMACOGENETICS AND BIOMARKERS IN THE SELECTION OF ANTIHYPERTENSIVE AND ANTIPLATELET AGENTS - POTENTIAL AND LIMITATIONS OF IMPLEMENTATION” (2026) Genetics and Molecular Research [Preprint]. doi:10.4238/z3e7ft80.